JAKK Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment NTRSO Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment STKS Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment MELI Q1 2026 Earnings EPS Miss Despite Strong Operational Momentum PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage